- Home
- CISO vs RADX Comparison
CISO vs RADX Comparison
Compare CISO & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- RADX
- Stock Information
- Founded
- CISO 2015
- RADX 2021
- Country
- CISO United States
- RADX Australia
- Employees
- CISO N/A
- RADX N/A
- Industry
- CISO Computer Software: Prepackaged Software
- RADX
- Sector
- CISO Technology
- RADX
- Exchange
- CISO Nasdaq
- RADX NYSE
- Market Cap
- CISO 31.4M
- RADX 32.5M
- IPO Year
- CISO N/A
- RADX N/A
- Fundamental
- Price
- CISO $1.08
- RADX $4.43
- Analyst Decision
- CISO
- RADX Strong Buy
- Analyst Count
- CISO 0
- RADX 2
- Target Price
- CISO N/A
- RADX $13.50
- AVG Volume (30 Days)
- CISO 969.5K
- RADX 19.9K
- Earning Date
- CISO 08-13-2025
- RADX 02-26-2025
- Dividend Yield
- CISO N/A
- RADX N/A
- EPS Growth
- CISO N/A
- RADX N/A
- EPS
- CISO N/A
- RADX N/A
- Revenue
- CISO $29,887,603.00
- RADX $204,609.00
- Revenue This Year
- CISO N/A
- RADX N/A
- Revenue Next Year
- CISO N/A
- RADX N/A
- P/E Ratio
- CISO N/A
- RADX N/A
- Revenue Growth
- CISO N/A
- RADX N/A
- 52 Week Low
- CISO $0.26
- RADX $3.50
- 52 Week High
- CISO $3.84
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- CISO 47.60
- RADX N/A
- Support Level
- CISO $0.97
- RADX N/A
- Resistance Level
- CISO $1.19
- RADX N/A
- Average True Range (ATR)
- CISO 0.08
- RADX 0.00
- MACD
- CISO -0.01
- RADX 0.00
- Stochastic Oscillator
- CISO 38.41
- RADX 0.00
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.